The subject invention concerns materials and methods for inhibiting the Akt/PKB pathway. In one embodiment, a compound of the invention inhibits kinase activity and/or phosphorylation levels of Akt proteins. The subject invention also concerns methods for inhibiting or killing a cancer cell or other cell in which expression of an Akt protein is elevated or constitutively active, comprising contacting the cell with an effective amount of a compound of formula I. The subject invention also concerns methods for treating cancer or a tumor in a person or animal comprising administering all effective amount of a compound of formula I to the person or animal
The deregulation of oncogenic signaling pathways which provide survival advantages to tumor cells is...
The subject invention pertains to uses of PKC-iota inhibitors for treatment of breast cancer. In one...
Akt is a serine/threonine kinase that transduces survival signals from survival/growth factors. Dere...
The subject invention concerns materials and methods for inhibiting the Akt/PKB pathway. In one embo...
The subject invention concerns materials and methods for inhibiting the Akt/PKB pathway. In one embo...
Protein kinase B (PKB, also called Akt) is an important regulator of cell proliferation and survival...
The invention provides a compound that is an inhibitor of one or both of TBK1 and IKKe, or a down-re...
Compounds of the substituted pyrazole class as treatments for cancer are reported. A method of treat...
The present invention relates to compounds having cytostatic activity against tumor cells
ABSTRACT: We describe a novel, potent peptide substrate mimetic inhibitor of protein kinase B (PKB/ ...
The invention provides novel compounds based on piperazinylpyrimidine derivatives to be used as prot...
Compositions, kits and methods for treating cancer in a subject in need thereof are disclosed involv...
Compositions, kits and methods for treating cancer in a subject in need thereof are disclosed involv...
The subject invention concerns compounds having activity as inhibitors of proteasomes and methods of...
AbstractAkt is a serine/threonine kinase that transduces survival signals from survival/growth facto...
The deregulation of oncogenic signaling pathways which provide survival advantages to tumor cells is...
The subject invention pertains to uses of PKC-iota inhibitors for treatment of breast cancer. In one...
Akt is a serine/threonine kinase that transduces survival signals from survival/growth factors. Dere...
The subject invention concerns materials and methods for inhibiting the Akt/PKB pathway. In one embo...
The subject invention concerns materials and methods for inhibiting the Akt/PKB pathway. In one embo...
Protein kinase B (PKB, also called Akt) is an important regulator of cell proliferation and survival...
The invention provides a compound that is an inhibitor of one or both of TBK1 and IKKe, or a down-re...
Compounds of the substituted pyrazole class as treatments for cancer are reported. A method of treat...
The present invention relates to compounds having cytostatic activity against tumor cells
ABSTRACT: We describe a novel, potent peptide substrate mimetic inhibitor of protein kinase B (PKB/ ...
The invention provides novel compounds based on piperazinylpyrimidine derivatives to be used as prot...
Compositions, kits and methods for treating cancer in a subject in need thereof are disclosed involv...
Compositions, kits and methods for treating cancer in a subject in need thereof are disclosed involv...
The subject invention concerns compounds having activity as inhibitors of proteasomes and methods of...
AbstractAkt is a serine/threonine kinase that transduces survival signals from survival/growth facto...
The deregulation of oncogenic signaling pathways which provide survival advantages to tumor cells is...
The subject invention pertains to uses of PKC-iota inhibitors for treatment of breast cancer. In one...
Akt is a serine/threonine kinase that transduces survival signals from survival/growth factors. Dere...